JP2022547061A5 - - Google Patents
Info
- Publication number
- JP2022547061A5 JP2022547061A5 JP2022514608A JP2022514608A JP2022547061A5 JP 2022547061 A5 JP2022547061 A5 JP 2022547061A5 JP 2022514608 A JP2022514608 A JP 2022514608A JP 2022514608 A JP2022514608 A JP 2022514608A JP 2022547061 A5 JP2022547061 A5 JP 2022547061A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025097923A JP2025148350A (ja) | 2019-09-05 | 2025-06-11 | 進展型小細胞肺癌（ｅｓ－ｓｃｌｃ）の治療のための組成物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962896224P | 2019-09-05 | 2019-09-05 | |
| US62/896,224 | 2019-09-05 | ||
| PCT/EP2020/074714 WO2021043955A1 (en) | 2019-09-05 | 2020-09-04 | Compositions and methods for treating extensive stage small cell lung cancer (es-sclc) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025097923A Division JP2025148350A (ja) | 2019-09-05 | 2025-06-11 | 進展型小細胞肺癌（ｅｓ－ｓｃｌｃ）の治療のための組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022547061A JP2022547061A (ja) | 2022-11-10 |
| JPWO2021043955A5 JPWO2021043955A5 (https=) | 2023-09-11 |
| JP2022547061A5 true JP2022547061A5 (https=) | 2023-09-11 |
Family
ID=72521575
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514608A Pending JP2022547061A (ja) | 2019-09-05 | 2020-09-04 | 進展型小細胞肺癌（ｅｓ－ｓｃｌｃ）の治療のための組成物及び方法 |
| JP2025097923A Pending JP2025148350A (ja) | 2019-09-05 | 2025-06-11 | 進展型小細胞肺癌（ｅｓ－ｓｃｌｃ）の治療のための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025097923A Pending JP2025148350A (ja) | 2019-09-05 | 2025-06-11 | 進展型小細胞肺癌（ｅｓ－ｓｃｌｃ）の治療のための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12012453B2 (https=) |
| EP (1) | EP4025249A1 (https=) |
| JP (2) | JP2022547061A (https=) |
| KR (1) | KR20220058601A (https=) |
| CN (1) | CN114340673A (https=) |
| AU (2) | AU2020342713A1 (https=) |
| CA (1) | CA3151838A1 (https=) |
| IL (1) | IL290834A (https=) |
| TW (1) | TWI907357B (https=) |
| WO (1) | WO2021043955A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119255817A (zh) * | 2022-03-28 | 2025-01-03 | 齐鲁制药有限公司 | 包含抗ctla4和抗pd1的混合抗体的药物组合物及其治疗用途 |
| TW202602492A (zh) * | 2024-04-05 | 2026-01-16 | 瑞典商阿斯特捷利康公司 | 局限期小細胞肺癌之治療 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7109003B2 (en) | 1998-12-23 | 2006-09-19 | Abgenix, Inc. | Methods for expressing and recovering human monoclonal antibodies to CTLA-4 |
| NZ628923A (en) | 2009-11-24 | 2016-02-26 | Medimmune Ltd | Targeted binding agents against b7-h1 |
| EP3277318A1 (en) * | 2015-04-01 | 2018-02-07 | Medimmune Limited | Combined anti-pld-1 and anti-ctla-4 antibodies for treating non-small lung cancer |
| US20160347848A1 (en) * | 2015-05-28 | 2016-12-01 | Medimmune Limited | Therapeutic combinations and methods for treating neoplasia |
| ES2980794T3 (es) * | 2015-09-15 | 2024-10-03 | Acerta Pharma Bv | Combinaciones terapéuticas de un inhibidor de CD19 y un inhibidor de BTK |
| AR108468A1 (es) * | 2016-05-13 | 2018-08-22 | Medimmune Llc | POLIPÉPTIDOS DE FUSIÓN CD40L-Fc Y MÉTODOS DE USO DE LOS MISMOS |
| SG10202110707UA (en) * | 2017-03-30 | 2021-11-29 | Merck Patent Gmbh | Combination of an anti-pd-l1 antibody and a dna-pk inhibitor for the treatment of cancer |
| CN112585166A (zh) * | 2018-06-23 | 2021-03-30 | 豪夫迈·罗氏有限公司 | 用pd-1轴结合拮抗剂、铂剂和拓扑异构酶ii抑制剂治疗肺癌的方法 |
-
2020
- 2020-09-04 US US17/012,643 patent/US12012453B2/en active Active
- 2020-09-04 AU AU2020342713A patent/AU2020342713A1/en not_active Abandoned
- 2020-09-04 KR KR1020227011152A patent/KR20220058601A/ko active Pending
- 2020-09-04 CN CN202080062489.9A patent/CN114340673A/zh active Pending
- 2020-09-04 CA CA3151838A patent/CA3151838A1/en active Pending
- 2020-09-04 TW TW109130442A patent/TWI907357B/zh active
- 2020-09-04 EP EP20772218.2A patent/EP4025249A1/en active Pending
- 2020-09-04 JP JP2022514608A patent/JP2022547061A/ja active Pending
- 2020-09-04 WO PCT/EP2020/074714 patent/WO2021043955A1/en not_active Ceased
-
2022
- 2022-02-23 IL IL290834A patent/IL290834A/en unknown
-
2024
- 2024-05-07 US US18/657,210 patent/US20240376206A1/en active Pending
-
2025
- 2025-04-17 AU AU2025202735A patent/AU2025202735A1/en active Pending
- 2025-06-11 JP JP2025097923A patent/JP2025148350A/ja active Pending